Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overcoming resistance to imatinib by combining targeted agents.

× No keyword cloud information.

9 in total

1. Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responses.

Authors: Dominik Wodarz
Journal: Proc Biol Sci Date: 2010-02-10 Impact factor: 5.349

2. Molecular monitoring of chronic myelogenous leukemia: identification of the most suitable internal control gene for real-time quantification of BCR-ABL transcripts.

Authors: Y Lynn Wang; Joong Won Lee; Ethel Cesarman; David K Jin; Balazs Csernus
Journal: J Mol Diagn Date: 2006-05 Impact factor: 5.568

3. Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.

Authors: Delphine Lamoral-Theys; Laurent Pottier; Frédéric Kerff; François Dufrasne; Fabien Proutière; Nathalie Wauthoz; Philippe Neven; Laurent Ingrassia; Pierre Van Antwerpen; Florence Lefranc; Michel Gelbcke; Bernard Pirotte; Jean-Louis Kraus; Jean Nève; Alexander Kornienko; Robert Kiss; Jacques Dubois
Journal: Bioorg Med Chem Date: 2010-04-21 Impact factor: 3.641

4. Cellular Hierarchy as a Determinant of Tumor Sensitivity to Chemotherapy.

Authors: Ignacio A Rodriguez-Brenes; Antonina V Kurtova; Christopher Lin; Yu-Cheng Lee; Jing Xiao; Martha Mims; Keith Syson Chan; Dominik Wodarz
Journal: Cancer Res Date: 2017-02-24 Impact factor: 12.701

5. Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells.

Authors: Michael G Kharas; Matthew R Janes; Vanessa M Scarfone; Michael B Lilly; Zachary A Knight; Kevan M Shokat; David A Fruman
Journal: J Clin Invest Date: 2008-09 Impact factor: 14.808

6. Optimizing combination therapies with existing and future CML drugs.

Authors: Allen A Katouli; Natalia L Komarova
Journal: PLoS One Date: 2010-08-23 Impact factor: 3.240

7. Novel structural co-expression analysis linking the NPM1-associated ribosomal biogenesis network to chronic myelogenous leukemia.

Authors: Lawrence W C Chan; Xihong Lin; Godwin Yung; Thomas Lui; Ya Ming Chiu; Fengfeng Wang; Nancy B Y Tsui; William C S Cho; S P Yip; Parco M Siu; S C Cesar Wong; Benjamin Y M Yung
Journal: Sci Rep Date: 2015-07-24 Impact factor: 4.379

8. Effect of cellular quiescence on the success of targeted CML therapy.

Authors: Natalia L Komarova; Dominik Wodarz
Journal: PLoS One Date: 2007-10-03 Impact factor: 3.240

9. Combination of two but not three current targeted drugs can improve therapy of chronic myeloid leukemia.

Authors: Natalia L Komarova; Allen A Katouli; Dominik Wodarz
Journal: PLoS One Date: 2009-02-10 Impact factor: 3.240

9 in total